GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » Total Assets

LifeTech Scientific (HKSE:01302) Total Assets : HK$5,137 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific Total Assets?

LifeTech Scientific's Total Assets for the quarter that ended in Dec. 2023 was HK$5,137 Mil.

Warning Sign:

If a company builds assets at 23.5% a year, faster than its revenue growth rate of 17% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, LifeTech Scientific's average Total Assets Growth Rate was 20.60% per year. During the past 3 years, the average Total Assets Growth Rate was 21.40% per year. During the past 5 years, the average Total Assets Growth Rate was 23.50% per year. During the past 10 years, the average Total Assets Growth Rate was 26.80% per year.

During the past 13 years, LifeTech Scientific's highest 3-Year average Total Assets Growth Rate was 62.50%. The lowest was 16.20%. And the median was 27.30%.

Total Assets is connected with ROA %. LifeTech Scientific's annualized ROA % for the quarter that ended in Dec. 2023 was 1.96%. Total Assets is also linked to Revenue through Asset Turnover. LifeTech Scientific's Asset Turnover for the quarter that ended in Dec. 2023 was 0.14.


LifeTech Scientific Total Assets Historical Data

The historical data trend for LifeTech Scientific's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Total Assets Chart

LifeTech Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,972.05 3,502.42 3,898.36 4,120.79 5,136.78

LifeTech Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,898.36 3,846.45 4,120.79 4,464.70 5,136.78

LifeTech Scientific Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

LifeTech Scientific's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=3635.688+1501.096
=5,137

LifeTech Scientific's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=3635.688+1501.096
=5,137

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeTech Scientific  (HKSE:01302) Total Assets Explanation

Total Assets is connected with ROA %.

LifeTech Scientific's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=94.236/( (4464.701+5136.784)/ 2 )
=94.236/4800.7425
=1.96 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

LifeTech Scientific's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=686.532/( (4464.701+5136.784)/ 2 )
=686.532/4800.7425
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

LifeTech Scientific Total Assets Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific (HKSE:01302) Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
Executives
Xie Yuehui 2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited 2101 Beneficial owner
Hhlr Advisors, Ltd. 2102 Investment manager
Bank Of Communications Trustee Limited 2301 Trustee
Xie Yuehui 2201 Interest of corporation controlled by you
Hhlr Fund, L.p. 2101 Beneficial owner
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines